claudemor supositorios
sankyo pharma venezuela,s.a. - clauden - supositorio - 10 mg
combizym fort grageas
sankyo pharma venezuela,s.a. - enzimas pancreaticas - gragea - ver formula (a)
dermofix 2 % crema
sankyo pharma venezuela,s.a. - sertaconazol - crema - 2 %
dermofix 2 % polvo
sankyo pharma venezuela,s.a. - sertaconazol - polvo de uso topico - 2 %
dermofix 2 % solucion topica
sankyo pharma venezuela,s.a. - sertaconazol - solucion para uso topico - 2 %
mevalotin 10 mg tabletas
sankyo pharma venezuela,s.a. - pravastatina sodica - tableta - 10 mg (a1)
rezulin 200 mg tabletas
sankyo pharma venezuela,s.a. - troglitazona - tableta - 200 mg
viavox 25 mg grageas
sankyo pharma venezuela,s.a. - diclofenac sodico - gragea - 25 mg (a1)
viavox 75 mg capsulas de liberacion prolongada
sankyo pharma venezuela,s.a. - diclofenac sodico - capsula de liberacion prolongada - 75 mg (a1)
vanflyta
daiichi sankyo europe gmbh - quizartinib dihydrochloride - leucemia, mieloide - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.